Benign rolandic epilepsy

Benign rolandic epilepsy is the indication for 1 drug in DrugBank. It is covered by 1 curated, structured indication.

Also known as: Epilepsy, Rolandic · Rolandic Epilepsy · Benign Childhood Epilepsy With Centro-Temporal Spikes · Benign Childhood Epilepsy With Centrotemporal Spikes · Benign Childhood Epilepsy With Centro-temporal Spikes (BCECTS)
Classified under: Congenital, Hereditary, and Neonatal Diseases and Abnormalities
Mental Disorders
Nervous System Diseases
Signs, Symptoms, and General Pathologies
Indicated drugs: Sulthiame

Resolves to

Vocabularies

MeSHM0028742SNOMED CT193024005MedDRA10070530UMLSC0376532

What you can answer from here — as of November 08, 2026

1Indicated drugWith each drug's targets and mechanism

Listed above

1Structured indicationPopulation, line of therapy, route and combination as fields, not prose

6Clinical trialsPhase, status and sponsor resolved per trial

Which approved drugs for Benign rolandic epilepsy share a target, and which companies have late-stage candidates against it?

Create a free account or log in to explore the full data card.